Guggenheim Capital’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Buy
96,321
+36,786
+62% +$725K 0.01% 731
2025
Q4
$1.13M Buy
59,535
+19,424
+48% +$360K 0.01% 889
2025
Q3
$748K Sell
40,111
-17,192
-30% -$321K 0.01% 1025
2025
Q2
$1.06M Sell
57,303
-1,122
-2% -$19.9K 0.01% 870
2025
Q1
$1.02M Sell
58,425
-10,516
-15% -$177K 0.01% 870
2024
Q4
$1.19M Sell
68,941
-143,382
-68% -$2.62M 0.01% 837
2024
Q3
$3.95M Sell
212,323
-473,160
-69% -$7.98M 0.03% 601
2024
Q2
$10.6M Sell
685,483
-36,968
-5% -$528K 0.08% 287
2024
Q1
$10.7M Buy
722,451
+33,122
+5% +$459K 0.08% 303
2023
Q4
$9.84M Buy
689,329
+298,361
+76% +$4.24M 0.07% 315
2023
Q3
$5.45M Sell
390,968
-32,270
-8% -$413K 0.05% 460
2023
Q2
$4.98M Sell
423,238
-11,874
-3% -$135K 0.04% 522
2023
Q1
$5M Buy
435,112
+65,767
+18% +$814K 0.04% 527
2022
Q4
$4.59M Buy
369,345
+110,742
+43% +$1.41M 0.04% 555
2022
Q3
$3.39M Buy
258,603
+7,894
+3% +$117K 0.03% 641
2022
Q2
$3.5M Buy
250,709
+19,332
+8% +$258K 0.03% 683
2022
Q1
$3.44M Buy
231,377
+60,391
+35% +$826K 0.02% 804
2021
Q4
$2.32M Buy
170,986
+102,206
+149% +$1.45M 0.01% 986
2021
Q3
$1.01M Sell
68,780
-24,381
-26% -$412K 0.01% 1408
2021
Q2
$1.7M Sell
93,161
-6,250
-6% -$111K 0.01% 1192
2021
Q1
$1.73M Sell
99,411
-507,480
-84% -$8.92M 0.01% 1110
2020
Q4
$10.5M Sell
606,891
-21,400
-3% -$342K 0.07% 324
2020
Q3
$8.66M Buy
628,291
+40,046
+7% +$588K 0.06% 329
2020
Q2
$8.49M Buy
588,245
+269,065
+84% +$3.54M 0.07% 325
2020
Q1
$3.48M Buy
319,180
+259,301
+433% +$4.78M 0.04% 589
2019
Q4
$1.28M Sell
59,879
-6,590
-10% -$148K 0.01% 1240
2019
Q3
$1.53M Sell
66,469
-10,197
-13% -$217K 0.01% 1119
2019
Q2
$1.51M Buy
76,666
+17,625
+30% +$343K 0.01% 1166
2019
Q1
$1.15M Sell
59,041
-177,935
-75% -$3.37M 0.01% 1312
2018
Q4
$3.9M Buy
236,976
+160,307
+209% +$3.23M 0.04% 695
2018
Q3
$1.77M Sell
76,669
-5,942
-7% -$135K 0.01% 1306
2018
Q2
$1.79M Sell
82,611
-137,152
-62% -$2.68M 0.01% 1313
2018
Q1
$3.88M Sell
219,763
-303,160
-58% -$5.34M 0.01% 1164
2017
Q4
$9.82M Sell
522,923
-23,246
-4% -$462K 0.02% 698
2017
Q3
$12M Buy
546,169
+450,785
+473% +$10.2M 0.03% 617
2017
Q2
$2.3M Buy
95,384
+1,436
+2% +$36.5K 0.01% 1533
2017
Q1
$2.62M Sell
93,948
-20,442
-18% -$536K 0.01% 1458
2016
Q4
$2.79M Buy
114,390
+39,784
+53% +$912K 0.01% 1421
2016
Q3
$1.88M Sell
74,606
-6,029
-7% -$144K 0.01% 1659
2016
Q2
$1.66M Sell
80,635
-2,368
-3% -$49.4K 0.01% 1683
2016
Q1
$1.67M Sell
83,003
-1,339
-2% -$25.7K 0.01% 1692
2015
Q4
$1.71M Sell
84,342
-126,907
-60% -$2.67M 0.01% 1732
2015
Q3
$4.9M Sell
211,249
-87,849
-29% -$2.24M 0.02% 1046
2015
Q2
$7.7M Buy
299,098
+135,566
+83% +$3.85M 0.02% 957
2015
Q1
$5.42M Buy
163,532
+32,870
+25% +$1.07M 0.01% 1136
2014
Q4
$3.97M Sell
130,662
-111,471
-46% -$3.07M 0.01% 1248
2014
Q3
$5.89M Buy
242,133
+133,798
+124% +$3.71M 0.01% 1118
2014
Q2
$3.11M Buy
108,335
+18,139
+20% +$527K 0.01% 1475
2014
Q1
$2.52M Buy
90,196
+23,239
+35% +$638K 0.01% 1598
2013
Q4
$1.75M Sell
66,957
-13,951
-17% -$360K 0.01% 1891
2013
Q3
$1.86M Sell
80,908
-6,106
-7% -$150K 0.01% 1665
2013
Q2
$2.27M Buy
+87,014
New +$2.51M 0.01% 1449

Other funds holding SBRA